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ABSTRACT
Background Available evidence on the comparative 
efficacy and acceptability of psychotherapies for post- 
traumatic stress disorder (PTSD) in children and adolescents 
remains uncertain.
Objective We aimed to compare and rank the different 
types and formats of psychotherapies for PTSD in children 
and adolescents.
Methods We searched eight databases and other 
international registers up to 31 December 2020. The 
pairwise meta- analyses and frequentist network meta- 
analyses estimated pooled standardised mean differences 
(SMDs) and ORs with random- effects model. Efficacy at 
post- treatment and follow- up, acceptability, depressive and 
anxiety symptoms were measured.
Findings We included 56 randomised controlled trials 
with 5327 patients comparing 14 different types of 
psychotherapies and 3 control conditions. For efficacy, 
cognitive processing therapy (CPT), behavioural therapy (BT), 
individual trauma- focused cognitive–behavioural therapy 
(TF- CBT), eye movement desensitisation and reprocessing, 
and group TF- CBT were significantly superior to all control 
conditions at post- treatment and follow- up (SMDs between 
−2.42 and −0.25). Moreover, CPT, BT and individual TF- CBT 
were more effective than supportive therapy (SMDs between 
−1.92 and −0.49). Results for depressive and anxiety 
symptoms were similar to the findings for the primary 
outcome. Most of the results were rated as ’moderate’ to 
’very low’ in terms of confidence of evidence.
Conclusions CPT, BT and individual TF- CBT appear to 
be the best choices of psychotherapy for PTSD in young 
patients. Other types and different ways of delivering 
psychological treatment can be alternative options. Clinicians 
should consider the importance of each outcome and the 
patients’ preferences in real clinical practice.
BACKGROUND
Post- traumatic stress disorder (PTSD) is a common 
and severe psychological disorder in children and 
adolescents.1 About 30%–60% of young people 
who have experienced traumatic events can develop 
PTSD.2 Types of traumatic events that may cause 
PTSD in children and adolescents mainly include 
physical or sexual abuse, war or terrorism, natural 
or man- made disasters, catastrophic illnesses and 
accidents.3 Additionally, prolonged, repeated 
experience of trauma in a context in which the 
individual has little or no chance of escape may 
cause complex PTSD.4 Compared with adults, chil-
dren and adolescents with PTSD reported higher 
levels of anxiety and depression, and lower levels 
of optimal functioning in different settings (eg, at 
home and school).5 Moreover, untreated PTSD is 
a key determinant for poor health outcomes, such 
as elevated risk of psychiatric disorders or suicid-
ality, highlighting the importance of identifying 
and addressing psychological needs of traumatised 
minors.6
Currently, psychotherapies are recommended 
as the first- line treatment of PTSD in children 
and adolescents according to several international 
guidelines, and various forms of psychotherapies 
such as trauma- focused cognitive–behavioural 
therapy (TF- CBT) and eye movement desensiti-
sation and reprocessing (EMDR) are commonly 
used.7 8 Previous pairwise meta- analyses found 
evidence to support the effectiveness of psycho-
therapies in reducing PTSD, anxiety and depression 
symptoms.9 10 However, these studies were incon-
clusive because they were not able to generate clear 
hierarchies among available interventions, due to 
many psychotherapies that have not been directly 
compared. Moreover, the debate regarding whether 
the inclusion of a trauma- focused component (eg, 
exposure to traumatic memories) is essential in 
CBT11 and whether the effectiveness of psycho-
therapy delivered individually or in group format 
is different for children and adolescents with PTSD 
is still ongoing.12 These issues make decision- 
making uncertain for healthcare professionals and 
patients.13 14
Objective
In this study, we aimed to synthesise, compare and 
rank all the available evidence on commonly used 
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METHODS
Search strategy and selection criteria
We performed a comprehensive literature search for published 
and unpublished randomised controlled trials (RCTs) in PubMed, 
Cochrane Central Register of Controlled Trials, Embase, Web of 
Science, PsycINFO, CINAHL, PILOTS, ProQuest Dissertations, 
international trial registers from inception until 31 December 
2020 (online supplemental appendix 1). Eligible trials included 
comparisons of any manualised or structured psychotherapy 
with another psychotherapy or any control condition for the 
treatment of children and adolescents (≤18 years old) with a 
primary diagnosis of PTSD, as follows: (1) full PTSD, as diag-
nosed according to standardised diagnostic interviews, such 
as the Diagnostic and Statistical Manual of Mental Disorders 
(DSM) or International Classification of Diseases (ICD); (2) 
subclinical PTSD, patients who have experienced psychological 
trauma and report some subsequent PTSD symptoms in at least 
one of the four symptom clusters according to DSM- 5 (re- expe-
riencing, avoidance, hyperarousal, negative alterations in cogni-
tion and mood)15; (3) clinically significant post- traumatic stress 
symptoms (PTSS), defined as scoring above a validated cut- off 
on a rating scale.16 Trials involving patients with comorbid 
psychiatric disorders, such as depressive disorder or anxiety 
disorder, were included. Trials involving patients with acute 
stress disorder or adjustment disorder, combination therapies 
and an overall sample size of less than 10 patients were excluded. 
We contacted the authors to supplement incomplete reports of 
the original papers or provide data for unpublished studies. No 
restriction was applied for language. Different types and delivery 
formats of psychotherapies may have different effects, thus we 
decided a priori to consider them as independent nodes in the 
network meta- analysis, as applicable.17 The control conditions 
included no treatment (NT), treatment as usual (TAU) and 
waitlist (WL) (for detailed descriptions of these psychother-
apies and psychological control conditions, see online supple-
mental appendix 2). During psychotherapies, the patients and 
the therapists cannot be blinded to treatment allocation.18 As a 
consequence, we included only trials in which patients assessed 
symptoms by self- rating scales as well as trials in which observer/
raters were blinded.
Two researchers (YX and YZ) independently screened eligible 
trials, extracted the relevant information and assessed risk of 
bias with the Cochrane Collaboration’s risk of bias V.2.0 tool.19 
We resolved any discrepancies by consensus and arbitration by 
a panel of other investigators within the review team (XZ and 
PX). We also assessed the confidence of evidence contributing 
to each network estimate using the Confidence In Network 
Meta- Analysis (CINeMA) software (https:// cinema. ispm. unibe. 
ch/).20
Outcomes
The primary outcomes were efficacy (the endpoint score from 
PTSD symptom scales) at post- treatment and follow- up (up to 12 
months) and acceptability (all- cause discontinuation measured by 
the proportion of patients who withdrew from the study for any 
reason at post- treatment). Secondary outcomes were depressive 
symptoms (the endpoint score on depressive symptom scales) 
and anxiety symptoms (the endpoint score on anxiety symptom 
scales). Where PTSD symptoms were measured in a trial using 
more than one scale, we followed the hierarchy based on psycho-
metric properties and appropriateness for use with children and 
adolescents, as published in our protocol.17 We preferred self- 
rated outcome over the parent- rated or clinician- rated outcome, 
because the effect sizes have been shown to be more conservative 
in the self- rated outcomes.21
Data analysis
We first performed a series of pairwise meta- analysis of direct 
evidence and then a network meta- analysis combining direct and 
indirect evidence in a random- effects frequentist hierarchical 
model. Details of the applied statistical approaches are provided 
in online supplemental appendix 3. We used standardised mean 
differences (SMDs, Cohen’s d) to summarise data of continuous 
outcomes and ORs for dichotomous outcomes, with 95% CIs, 
respectively.22 WL was used as the reference control condition 
in all forest plots.23
To assess transitivity, we compared the distribution of clin-
ical and methodological variables across treatment compar-
isons. Those variables included publication year, mean age, 
the percentage of female patients, sample size and number of 
treatment session. We used the magnitude of the heterogeneity 
variance parameter (τ2 and total I² statistic) to assess the entire 
network heterogeneity across the various treatment comparisons. 
Incoherence between direct and indirect sources of evidence 
was assessed using a global (design- by- treatment inconsistency 
model) and a local (by calculation of the difference between 
direct and indirect estimates in all closed loops in the network) 
method.24 We also used the node- splitting method to separate 
evidence on a particular comparison into direct and indirect 
evidence to calculate the incoherence of the model.25 We used 
P- scores to rank interventions on the basis of the degree of effi-
cacy or acceptability, which is based on a frequentist analogue of 
‘Surface under the Cumulative Ranking Curve’.26 To determine 
whether the results were affected by study characteristics, we did 
a meta- regression for each outcome according to the following 
variables: publication year, mean age, the percentage of female 
patients, sample size, number of treatment sessions, treatment 
duration, follow- up duration, mean baseline severity of PTSD, 
risk of bias, trauma types, diagnosis criteria, source of outcome 
measure and psychiatric comorbidities.27 Additionally, we 
carried out prespecified sensitivity analyses for each outcome by 
omitting trials with unpublished data assessment and trials with 
high risk of bias. We also plotted a comparison- adjusted funnel 
plot and used Egger’s test to detect the presence of any dominant 
publication bias.28 The protocol has been registered with PROS-
PERO (CRD42016051786) and subsequently published.17 The 
minor changes to the original protocol are listed in the online 
supplemental appendix 4.
Findings
We identified 9073 citations, retrieved the full text of 404 poten-
tially eligible articles and included 56 RCTs (5327 patients) 
published between 1996 and 2020 (figure 1). We retrieved 
unpublished information for four (7.1%) studies, and identified 
two (3.6%) completely unpublished trials. Overall, 14 structured 
psychotherapies, including group TF- CBT, individual TF- CBT, 
group non- TF- CBT, individual non- TF- CBT, parent- only 
TF- CBT, EMDR, BT, cognitive processing therapy (CPT), cogni-
tive therapy (CT), psychodynamic therapy (DYN), play therapy 
(PT), stress management (SM), family therapy (FT), supportive 
therapy (ST) and three control conditions (WL, NT, TAU) were 
analysed in this study.
The characteristics of included trials are summarised in online 
supplemental appendices 4 and 5. The mean study sample size 
was 95 (range, 16–640). The mean age was 12.0 years (range, 
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(28.6%) trials enrolled only adolescents (≥13 and ≤18); and the 
remaining studies enrolled both children and adolescents. More 
than half (56.7%) of the patients were female. Overall, 3629 
(68.1%) of 5327 patients had moderate to severe PTSD, with 
a mean transformed baseline severity score on the Child Post-
traumatic Symptom Scale of 26.1 (SD 4.5). The median dura-
tion of the treatment was 10 weeks (IQR, 7–12) and the median 
follow- up assessment was 6 months (IQR, 3–12) after the end of 
treatment. The median number of sessions was 10 (IQR, 7–12). 
Twenty- two (39.3%) studies were carried out in North America, 
14 (25.0%) in Europe, 12 (21.4%) in Asia, 4 (7.1%) in Australia 
and 4 (7.1%) in Africa. Twenty- six (46.4%) studies recruited 
single traumatised patients, and 30 (53.6%) recruited multiple 
traumatised patients. Seventeen (30.3%) studies included 
patients with full PTSD, 6 (10.7%) with subclinical PTSD, 21 
(37.5%) with PTSS and the remaining of 12 (21.4%) with mixed 
levels of PTSD.
In terms of study quality, 13 (23.2%) trials were rated as high 
risk of bias, 26 (46.4%) trials as some concerns, 16 (28.6%) as 
low and 1 (1.8%) unpublished trial was impossible to assess 
(online supplemental appendix 6). figure 2 shows the network 
of eligible comparisons for efficacy at post- treatment. All 
psychotherapies, except for DYN, PT and SM, had at least one 
controlled trial, and 12 psychotherapies were directly compared 
with another active psychotherapy. Networks for other outcomes 
are displayed in online supplemental appendix 7.
Figure 1 Flow chart of study selection. Some studies assessed more than one type of psychotherapy. BT, behavioural therapy; CPT, cognitive 
processing therapy; CT, cognitive therapy; DYN, psychodynamic therapy; EMDR, eye movement desensitisation and reprocessing; FT, family therapy; PT, 
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Pairwise meta-analyses
For efficacy at post- treatment, CPT, CT, group non- TF- CBT, 
individual TF- CBT, ST, EMDR and group TF- CBT were more 
efficacious than WL. For efficacy at follow- up, CPT, BT, indi-
vidual TF- CBT and group TF- CBT were more efficacious than 
WL. For acceptability, EMDR, individual TF- CBT and FT were 
associated with more dropouts than one of the control condi-
tions; ST was more acceptable than WL. Detailed results of the 
other pairwise meta- analyses are shown in online supplemental 
appendix 8.
Network meta-analysis
In terms of efficacy at post- treatment (54 RCTs, 4625 patients), 
CPT, CT, BT, group non- TF- CBT, individual TF- CBT and 
EMDR were significantly more effective than all control condi-
tions (SMD range, −1.40 to −0.46). In addition, CPT, BT and 
individual TF- CBT were significantly more beneficial than ST 
(SMD range, −1.08 to −0.58, figures 3 and 4A). For efficacy 
at follow- up (31 RCTs, 2791 patients), CPT, BT, SM, individual 
TF- CBT and EMDR were more effective than all control condi-
tions and ST (SMD range, −2.42 to −0.41), and group TF- CBT 
more than control conditions (SMD range, −0.82 to −0.25). 
Moreover, CPT, BT and SM were superior to group non- 
TF- CBT, individual TF- CBT and group TF- CBT (SMD range, 
−1.63 to −0.69, figures 3 and 4B). In terms of acceptability 
(50 RCTs, 4640 patients), FT was linked to more dropouts than 
most of psychotherapies and all control conditions (OR range, 
0.02–0.16, figures 4C and 5). On the contrary, no treatment 
condition had fewer dropouts than most of psychotherapies, 
as well as TAU and WL (OR range, 0.02–0.18). Results for 
secondary outcomes of depressive symptoms and anxiety symp-
toms were not materially different from, and lent support to the 
findings for primary outcomes (online supplemental appendices 
9 and 10).
Heterogeneity, transitivity, inconsistency and meta-regression 
analyses
The global I2 values were 74.6% for efficacy at post- treatment, 
33.6% for efficacy at follow- up and 24.8% for acceptability 
(online supplemental appendix 11). The test of global inconsis-
tency did not show a significant difference between the consis-
tency and inconsistency models for efficacy at post- treatment 
(p=0.938), efficacy at follow- up (p=0.906) and acceptability 
(p=0.616, online supplemental appendix 11). Tests of local 
inconsistency showed small percentages of inconsistent loops for 
primary outcomes within the empirically expected range (4 of 
28 loops for the efficacy at post- treatment, 0 of 6 for efficacy 
at follow- up and 0 of 28 for acceptability). The test of inconsis-
tency from the node- splitting model showed significant differ-
ences between some comparisons in efficacy at post- treatment (1 
of 27), efficacy at follow- up (0 of 17) and acceptability (1 of 27). 
The assessment of transitivity showed some of the comparisons 
had variable publication year, mean age, percentage of women, 
sample size and number of treatment sessions, for instance, one 
comparison involving individual TF- CBT versus ST had rela-
tively large sample size with 229 (online supplemental appendix 
12). Egger’s tests for the comparison- adjusted funnel plot did 
not suggest potential publication bias or small- study effect for 
efficacy at post- treatment (p=0.054), efficacy at follow- up 
(p=0.749) or acceptability (p=0.449) (online supplemental 
appendix 13).
Network meta regression analyses showed most modifiers 
(online supplemental appendix 14) did not significantly affect 
the efficacy and acceptability of interventions; however, we 
found that studies with higher risk of bias were associated with 
smaller treatment effects at follow- up. The sensitivity anal-
yses did not substantially change the relative treatment effects 
(online supplemental appendix 14). The online supplemental 
appendix 15 presents the ranking of treatments based on the 
P- scores, which rank psychotherapies and control conditions on 
a continuous 0–1 scale. The contribution plot (online dataset 
available at http:// dx. doi. org/ 10. 17632/ 278y88n8r7. 1) shows 
the percentage of contributions of each outcome from the direct 
comparisons for the mixed and indirect estimates. According to 
CINeMA evaluation, for efficacy at post- treatment, 2.2% of all 
comparisons were rated as moderate confidence of evidence, 
7.4% as low and 90.4% as very low. For efficacy at follow- up, 
3.3% of all comparisons were rated as high confidence of 
evidence, 25.3% as moderate, 16.5% as low and 54.9% as very 
low. In terms of the acceptability, 11.7% were rated as moderate 
confidence of evidence, 2.5% as low and 85.8% as very low 
(online supplemental appendix 16).
DISCUSSION
To our knowledge, this is the most comprehensive network 
meta- analysis assessing psychotherapy for PTSD in children 
and adolescents. It is based on 56 trials including 5327 patients 
randomly assigned to 14 different structured psychothera-
pies and 3 control conditions. We extended and improved a 
previous study29 by searching additional unpublished databases 
and several international trial registers, by investigating three 
Figure 2 Network of eligible comparisons for efficacy at post- 
treatment. The width of the lines is proportional to the number of 
trials comparing every pair of treatments, and the size of every node 
is proportional to the number of randomised patients. BT, behavioural 
therapy; CPT, cognitive processing therapy; CT, cognitive therapy; DYN, 
psychodynamic therapy; EMDR, eye movement desensitisation and 
reprocessing; FT, family therapy; G- nTF- CBT, group non- trauma- focused 
cognitive–behavioural therapy; G- TF- CBT, group trauma- focused 
cognitive–behavioural therapy; I- nTF- CBT, individual non- trauma- 
focused cognitive–behavioural therapy; I- TF- CBT, individual trauma- 
focused cognitive–behavioural therapy; NT, no treatment; PT, play 
therapy; P- TF- CBT, parent- only trauma- focused cognitive–behavioural 
therapy; SM, stress management; ST, supportive therapy; TAU, treatment 
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additional important outcomes (namely acceptability, depres-
sion symptoms and anxiety symptoms), and by using CINeMA 
to assess the certainty of evidence, and meta- regression anal-
yses to explore potential sources of heterogeneity.
Effect sizes suggest that about half of the psychothera-
pies reduced more PTSD symptoms than control conditions, 
ranging between −1.40 and −0.46. Only CPT, BT and indi-
vidual TF- CBT were significantly more efficacious than 
Figure 3 League table for efficacy at post- treatment and follow- up associated with different treatments. Treatments are ranked according to their 
P- scores of surface under the curve cumulative ranking for sedation starting with the best of efficacy at post- treatment. Results of the efficacy at 
post- treatment network meta- analysis are presented in the left lower half and results from efficacy at follow- up in the upper right half, if available. 
Comparisons between treatments should be read from left to right and the estimate is in the cell in common between the column- defining treatment 
and the row- defining treatment. For interpretation, a number less than zero favours the column- defining treatment of a cell, that is, this treatment 
leads to a decrease in endpoint score for PTSD symptom severity rating scales. Values depicted are standardised mean differences (SMDs) with 
associated 95% CIs. Significant results are in bold and underlined. BT, behavioural therapy; CPT, cognitive processing therapy; CT, cognitive therapy; 
DYN, psychodynamic therapy; EMDR, eye movement desensitisation and reprocessing; FT, family therapy; G- nTF- CBT, group non- trauma- focused 
cognitive–behavioural therapy; G- TF- CBT, group trauma- focused cognitive–behavioural therapy; I- nTF- CBT, individual non- trauma- focused cognitive–
behavioural therapy; I- TF- CBT, individual trauma- focused cognitive–behavioural therapy; NA, not available; NT, no treatment; PT, play therapy; P- TF- 
CBT, parent- only trauma- focused cognitive–behavioural therapy; PTSD, post- traumatic stress disorder; SM, stress management; ST, supportive therapy; 
TAU, treatment as usual; WL, waitlist.
Figure 4 Forest plots of network meta- analysis of all trials for efficacy and acceptability. (A) Efficacy at post- treatment. (B) Efficacy at follow- up. (C) 
All- cause discontinuation. Interventions were compared with waitlist (WL), which was the reference compound. *Significant results. Colours indicate 
the confidence in the evidence for a given comparison: blue is high, green is moderate, yellow is low and red is very low. Confidence of outcomes was 
graded using the Confidence In Network Meta- Analysis application. BT, behavioural therapy; CPT, cognitive processing therapy; CT, cognitive therapy; 
DYN, psychodynamic therapy; EMDR, eye movement desensitisation and reprocessing; FT, family therapy; G- nTF- CBT, group non- trauma- focused 
cognitive–behavioural therapy; G- TF- CBT, group trauma- focused cognitive–behavioural therapy; I- nTF- CBT, individual non- trauma- focused cognitive–
behavioural therapy; I- TF- CBT, individual trauma- focused cognitive–behavioural therapy; NT, no treatment; PT, play therapy; P- TF- CBT, parent- only 
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supportive therapy for the efficacy outcomes at post- treatment 
and follow- up; and CPT was among the most efficacious 
psychotherapies in this study. The main goal of CPT is to iden-
tify and modify dysfunctional thoughts through few formal 
exposure elements, Socratic dialogue and the systematic work-
sheets.30 In previous guidelines for PTSD in adults, CPT is 
one of the most extensively studied psychotherapies and has 
been recommended as the first- line psychological treatment,31 
while it has rarely been studied with only two WL- controlled 
studies32 33 in adolescents. The positive treatment effect in the 
present study might be explained by the capability to grasp 
cognitive components of psychotherapies and compliance of 
adolescent participants.34 This evidence may not be relevant 
to younger children and further studies are needed to properly 
assess CPT in children groups.
In our analyses, TF- CBT delivered in an individual format 
did not result in significantly different outcomes compared with 
group format. However, we found that individual TF- CBT, 
but not group TF- CBT, was more effective than TAU and ST. 
Similarly, previous studies suggested that, in adults with PTSD, 
individual psychotherapies were associated with substantially 
greater effect sizes compared with group psychotherapies.35 
One possible explanation is that, with an individual treatment 
format, the therapist can tailor psychotherapy to better meet 
the needs of the client than in a group- based intervention 
format. Other possible explanations are that because group 
TF- CBT for children was always conducted in classroom, it 
was difficult for the children to share their experiences and 
feelings openly in the presence of peers, or difficult to relax 
or concentrate during the sessions due to the school’s loud, 
chaotic environment.36
In our study, TF- CBT was significantly more effective than 
control conditions and some other psychotherapies in terms 
of PTSD symptoms at post- treatment and at follow- up, while 
non- TF- CBT did not show significant benefit compared with 
other psychotherapies. TF- CBT may result in less anxiety and 
fear for children by activating, disconfirming and confronting 
fear structures, and enhancing a broad spectrum of affective 
and behavioural functioning as well as child personal safety 
skills.37 These findings are consistent with the adult PTSD 
treatment literature that has documented the greater efficacy 
of TF- CBT approaches.38
According to our findings, no treatment condition had fewer 
dropouts than most of psychotherapies, as well as TAU and WL. 
However, the interpretation of the result should be done with 
much caution, because when someone is randomised to ‘NT’, 
this person can still find treatment elsewhere before post- test 
or follow- up (either with information about services provided 
in the trial or without).39 In addition, family therapy had more 
dropouts than most psychotherapies and all control conditions. 
We included only one study involving FT approaches, including 
their mothers, fathers and adolescent siblings.40 One possible 
reason is that gathering multiple family members for sessions 
at the same time is more difficult logistically than treating one 
person individually. Another possibility is suggested by the 
analysis from the original study showing that, dropouts from 
family therapy had higher levels of PTSS for family members at 
baseline compared with those who remained, this suggests that 
some of the most distressed families might not have completed 
the study. Thus, future work should properly examine whether 
the parents of young patients with PTSD may have elevated 
levels of PTSS or depressive and anxiety symptoms.
Figure 5 League table for all- cause discontinuation associated with different treatments. Treatments are ranked according to their P- scores of 
surface under the curve cumulative ranking for sedation starting with the best of acceptability. Comparisons between treatments should be read from 
left to right and the estimate is in the cell in common between the column- defining treatment and the row- defining treatment. For interpretation, a 
number less than one favours the column- defining treatment of a cell, that is, this treatment leads to a decrease in all- cause discontinuation. Values 
depicted are OR with associated 95% CIs. Significant results are in bold and underlined. BT, behavioural therapy; CPT, cognitive processing therapy; 
CT, cognitive therapy; DYN, psychodynamic therapy; EMDR, eye movement desensitisation and reprocessing; FT, family therapy; G- nTF- CBT, group non- 
trauma- focused cognitive–behavioural therapy; G- TF- CBT, group trauma- focused cognitive–behavioural therapy; I- nTF- CBT, individual non- trauma- 
focused cognitive–behavioural therapy; I- TF- CBT, individual trauma- focused cognitive–behavioural therapy; NT, no treatment; P- TF- CBT, parent- only 
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Our analysis has several limitations. First, in this study, the 
certainty of evidence for most outcomes was rated as low or 
very low. Although the global test of inconsistency was not 
significant for efficacy at post- treatment, the heterogeneity 
was considerable. Therefore, the interpretation and applica-
tion of the results of this study should be done with caution. 
Second, the classification of psychotherapy for PTSD in chil-
dren and adolescents remains controversial; for example, the 
forms and elements of CBT could be mixed, especially for 
some modified CBT, some studies viewed CPT as one type 
of CBT and combined them as one node in the network,23 29 
and TAU may be very different in various mental healthcare 
contexts. However, the assessment of transitivity in our anal-
ysis showed most of the comparisons had similar distribution 
of clinical and methodological variables. Third, although we 
excluded trials where psychotherapy was used as a combina-
tion strategy, some patients may have taken other treatments 
(eg, selective serotonin reuptake inhibitors), which might have 
led to a variation in effects of treatment.41 Furthermore, we did 
not exclude trials involving patients with comorbid psychiatric 
disorders, because a substantial proportion of the comorbid 
patients with depression and anxiety are seen in real world.42 
However, this may increase the risk of violating transitivity 
required of the network meta- analysis. Fourth, we were not 
able to assess some outcomes, such as adverse events discontin-
uation, suicidality, quality of life and functional improvement, 
because no available data were reported in the original studies. 
Fifth, even if the Egger’s test showed no significant publication 
bias for all outcomes, we found some potential asymmetry of 
funnel plots in this network meta- analysis, especially for the 
efficacy at post- treatment. In this study, we did our best to 
retrieve all available unpublished information and contacted 
study authors for supplementary information, but we cannot 
rule out the possibility that some unpublished studies are still 
missing.43 Finally, some findings of this study are limited by 
the small number and generally small size of identified studies, 
for example, some interventions (eg, DYN, FT, PT, parent- only 
TF- BT) were based on only a single study, some interventions 
(eg, CPT, BT) included almost adolescents but very few children 
and subgroup analyses or meta- regressions failed to perform 
for some characteristic (eg, study- conducted countries). Some 
meta- regression analyses (eg, mean age, mean baseline severity 
of PTSD, trauma types) were performed, however, they failed 
to show significant results, therefore, there was no enough 
evidence to conclude that children and adolescents with which 
particular characteristic could benefit more from psycholog-
ical therapies than others. These data should be analysed and 
contextualised at the individual patient level, without access to 
individual patient- level data; we cannot be completely confi-
dent about the accuracy of information contained in published 
studies or clinical study reports.44
CONCLUSIONS
This network meta- analysis suggests that CPT, BT and indi-
vidual TF- CBT appear to be good choices of psychotherapy 
for PTSD in young patients, while CPT appeared to produce 
more robust effects in adolescents. Other types of psychother-
apies and different ways of delivering psychological treatment 
(eg, EMDR, group TF- CBT) can be alternative options. Never-
theless, there were few differences in terms of efficacy and 
acceptability between those psychotherapies. Future guide-
lines for PTSD in children and adolescents should consider 
this updated comparative evidence. In real- world practice, 
interventions need to move beyond a ‘one size fits all’ to indi-
vidualising treatment, as part of this process, clinicians should 
consider the importance of each outcome and the patients’ 
preferences.
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